Versant Venture Capital V (Canada), LP's Net Worth

$23.9 Million

Estimate Recalculated Jun 28, 2024 04:32PM EST

Who is Versant Venture Capital V (Canada), LP?

Versant Venture Capital V (Canada), LP has an estimated net worth of $23.9 Million. This is based on reported shares across multiple companies, which include Turnstone Biologics Corp., Crinetics Pharmaceuticals, Inc., Gritstone Oncology, Inc., Repare Therapeutics Inc., CRISPR Therapeutics AG, and Aprea Therapeutics, Inc..

SEC CIK

Versant Venture Capital V (Canada), LP's CIK is 0001612235

Past Insider Trading and Trends

2021 was Versant Venture Capital V (Canada), LP's most active year for acquiring shares with 28 total transactions. Versant Venture Capital V (Canada), LP's most active month to acquire stocks was the month of September. 2021 was Versant Venture Capital V (Canada), LP's most active year for disposing of shares, totalling 42 transactions. Versant Venture Capital V (Canada), LP's most active month to dispose stocks was the month of May. 2019 saw Versant Venture Capital V (Canada), LP paying a total of $4,999,995.00 for 2,850,137 shares, this is the most they've acquired in one year. In 2022 Versant Venture Capital V (Canada), LP cashed out on 1,601,202 shares for a total of $9,188,775.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Turnstone Biologics Corp. (TSBX) Snapshot price: $2.5

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
3.38M
$12.00
—
3.38M
Jul 25
Form 3
—
0
—
—
0
No matching records found

Crinetics Pharmaceuticals, Inc. (CRNX) Snapshot price: $37.675

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-15.00%
-507.59K
—
—
2.88M
Feb 4
Form 4
+116.13%
3.38M
—
—
6.3M
Jul 20
Form 3
—
0
—
—
0
No matching records found

Gritstone Oncology, Inc. (GRTS) Snapshot price: $2.32

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
3.1M
—
—
3.1M
Oct 2
Form 3
—
0
—
—
0
No matching records found

Repare Therapeutics Inc. (RPTX) Snapshot price: $7.99

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-22.54%
-1.45M
$12.25
-$9,188,775.00
4.98M
Jun 3 - Jun 6
Form 4
-39.68%
-152.07K
—
—
231.21K
Scheduled
Aug 5
Form 4
-16.37%
-75.00K
—
—
383.28K
Jun 1
Form 4
-9.99%
-240.75K
—
—
2.17M
Scheduled
May 5
Form 4
-10.29%
-350.00K
—
—
3.05M
Scheduled
Feb 16
Form 4
-9.36%
-600.00K
—
—
5.81M
Scheduled
Jan 29
Form 4
-7.23%
-500.00K
—
—
6.41M
Scheduled
Jan 14
Form 4
-10.12%
-325.00K
—
—
2.88M
Scheduled
Dec 15
Form 4
+64.65%
6.5M
$20.00
$5,000,000.00
16.54M
Jun 23
Form 3
—
0
—
—
0
No matching records found

CRISPR Therapeutics AG (CRSP) Snapshot price: $66.91

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-1.30%
-22.84K
$50.90
-$1,164,655.40
1.73M
Scheduled
Apr 24
Form 4
-13.07%
-601.99K
$50.83
-$5,168,901.34
4M
Scheduled
Apr 20 - Apr 23
Form 4
-33.33%
-2.30M
—
—
4.61M
Sep 5
Form 4/A
+2,783.12%
6.67M
$14.00
—
6.91M
Oct 24
Form 4
+2.44%
161K
$14.00
$2,254,000.00
6.76M
Oct 24
Form 3
—
0
—
—
0
No matching records found